Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Moe, that 65 is not going to happen here. Peeps love to use scare tacticsto get investors to let go of their shares and drag down the pps. Investors don't let anyone scare you out of your investment. This week or shortly we will be getting notice of the deal closed between Navidea and Cardinal Health. The deal can be announced at any given day or hour.
There is no need for NAVB to pps to fall to 65 or 75 cents a share when the company has a pending contract deal worth $310 million with Cardinal Health inc. Plus at closing Navidea will received $80 million from that deal upfront. The $80 million will pay off debt and give the company funds to complete its rebust pipeline trial studies, Its Rheumatoid Arthritis study phase diagnostic drug, and its Cardiovascular disease study diagnostic drug. Which is expected to get FDA approval.
I have the feeling we're going to be getting a huge press release from Navidea this week. NAVB pps is going to soar very high when the PR is release. I hope it is release very early in the morning, before the market open.
Let's Go NAVB !!
your stock was looking like that today, but it bounce back just like NAVB is going to bounce back. Stocks does this quiet often. I just made a ton of my off of your stock today. And you know where I'am going to put it. I just increase my share count with NAVB.
No, peeps who are flippers can't wait for Navidea to close on it's deal with Cardinal Health. Flippers want their money 2 click up. True investor want their money when one can squeeze every penny out of their investment that can. Most let it run as high as it can, before taking profits. Flippers is a different type of species. Don't get me wrong I like flipping some stocks also, but never stock whom company has toss a big news warming out there in the public of a $80 million dollar upfront gain and a $310 million cap. Money going to ward of becoming debt free, and the continue of its rebust pipeline. I grab as many as those types of shares as I can and hold on. Those type of deals are not guick flipping shares.
*nwbo* is now taking a big fall. They don't have a $80 million dollar upfront deal offer at closing like NAVB, with a $310 million dollar cap offer. I think I will hold on to my car instead of trading it in for *nwbo*.
Agree, and that is why I love the phrase "know what you own". Know what you own by doing your own research, and pen down what it could be worth to you when all of the research is added up, not what is is worth for everyone else. for me it is worth 278k shares @ (?) pps when news is release of the close of the deal between Cardinal Health, inc and Navidea Biopharmaceuticals, inc. That is my secret price, of what I'am willing to sell my shares, not for no one else. My research, and patient is equal to a possibility of a big payday.
Let's Go NAVB.
Agree. Why take the chance to short Navidea when the company has made publicly known of a contract deal worth $80 million at closing, and a cap of $310. Plus the Navidea had also announced the name of the company (CAH). It will be financial suicidal to short NAVB this late in the game. It like playing poker with only a pair of 2's and thinking one is going to win the game when flipping their cards over with a big smile on they face, and saying beat this.
Shorts is not that dumb. At lease I hope they are not dumb.
Can you say, $3 to $5 once contract is signed and those $80 million are handed over at closing. Next positive news feedback from the Rheumatoid Arthritis update.
IMO, shorts is beginning to back off of NAVB.
Agree with you 100%, flippers, plus a few short sellers. Navidea is going to be doing small up and down bounces when flippers and shorts are in the house, but that is not much to worry about, especially when Navidea biopharmaceuticals is going to get a deal worth $80 million at closing and a cap of $310 million going forward. That is a sweet, sweet deal for Navidea and it's shareholders. I'am glad I'am one of them. NAVB is still holding up very well. It is doing better than most stocks in the same sector today. Navidea had a 10% move today.
Let's Go NAVB.
The market as a whole is down again today, but Navidea is holding its ground. We will be Okay. I'am sitting back with my heels kick-up on my desk watching the markets, and wondering why my son bought my truck back all muddy. It will be a long time before I let him borrow any vehicle that belongs to me again. Kids.
Amilik, enjoy your investment. Just thank about the good things you will and can do with the money, which Navidea is going to generate for many of us investors. When the market is down and my investment is up. I feel real good. That mean more eyes are on my investment.
Let's Go NAVB!!
And add to that Navidea has never missed or been late on a payment to CRG. CRG stated this in a swollen statement in court Navidea biopharmaceuticals inc has never missed a payment.
Patient, the signed contract will be release to public and markets.
The 2 companies Cardinal Health and Navidea Biopharmaceuticals are spending the time preparing to close a deal that will give Navidea an immediately $80 million in closing and a capped of $310 million. The pps will soar once this is completed and release to the markets. The most important is getting the deal closed so we all can get paid.
I total agree. There is a lot of interest in NAVB. I didn't notice the market was down very bad today. I was out and about trying to collect funds to add to my little stash at the library, and bank. It was about 30 minutes ago when I saw how low the whole market went down today. The Dow was at a loss of 394 points and the NASDAQ 133, S&P 53 WOW, and this is after closing. With all of this NAVB held its ground in the market today. It close tonight at .82 and that is a very good close for a down market today.
I also notice there was not any trading going with NAVB between the hours of 2:52 to 7:58. seem like investors and shareholders are holding on tightly to their investment. I made all of my trades before 2. Many of us know that the announcement of the signed deal could hit the market wires at any day, Day or Night, Pre Market, Regular market hours, or after closing. I hope it is a pre market announcement, and that it open up very high before the pre market trading begin. Maybe a surprise announcement of a completely buyout. Either way it goes the pps is going to soar.
I might leave some of the profit behind for the pipeline assets to reach maturity. IMO I believe the Rheumatoid Arthritis and Cardiovascular study drugs is going to reach maturity, and get FDA approval. Just my opinion.
My view is I just don't have any more funds available to pure into Navidea I scrape up the last few dollars I had available today from my annuity account to add to this cash cow. I don't know about everyone else, but I see this little gem turning into a cash cow when we get a market news press release (PRNewswire).I know I might be over exaggerating a little by using the term "cash cow". but amikik, I have been in spots like this before, and patient and timing is the key. I feel that many shareholders are anxious about the out come of the deal being signed and made known formerly to the public. Plus the big question is how much will it add to shareholder's value. IMOO We all just need to wait and see.
My opinion it is going to move up in $$$dollars$$$ land very fast when PR is release.
That's it amikik, calm before the storm (dull). Just a little bit more patient. Just like I had a little, and I mean just a little bit of patient, before they gave me back my true "alias" name to day. bullrider2 is back in the house, and I'am over whelm with excitement to have my alias name back. That is how it is going to be when Navidea biopharmaceuticals unleash that monstrous Wired Press Release it is going help make many shareholders here very excited to have held on for that monstrous PR that is going to line their bank accounts. Plus catch many off guard. Oh it is coming.
IMO once the SEC has okay the deal between Navidea Biopharmaceuticals, Inc and Cardinal Health, Inc. The company is going to fore-fill it goals of bring the assets in the pipeline into the markets. The Rheumatoid Arthritis and the Cardiovascular disease developing drug projects is going to be the next big money marker for Navidea. The company and investors are very excited about these 2 projects. Who knows we might still have CAH in the house to help to handle those 2 products. Maybe even Pfizer, Merck, j&j, and ect just to name a few.
But at the same time I still smell a buyout.
Digger, Cardinal Health inc is buying the rights to sell Lymphoseek in the North America, not the other parts of the world. Navidea will still hold the license to sale it's Lymohoseek product out side of North America. Cardinal is not buying the rights to sale, manufacture, market, or develop Lymphoseek out side of North America.
Navidea is to sale drug Lymphoseek to Cardinal Health inc to sell in North America. Navidea biopharmaceuticals inc will receive $80 million at closing capped $310 million Cardinal Health would license back to Navidea a portion of the acquired intellectual property. Navidea will be able to develop, manufacture, market that which don't compete with current Lymphoseek here in North America. Plus Navidea will be able to sale Lymphoseek out side of North America
Navidea will be developing their drug for Rheumatoid Arthritis (RA) And develop their drug for Cardiovascular disease / macrophages therapeutics pipeline. Navidea has 2 great products they has already begun developing. The Rheumatoid arthritis study and They are launching the Cardiovascular disease trial study.
The CEO in the conference mention Navidea will have a significant funds to pay debt such as CRG and to fund its development of its exciting pipeline assets.
Yes, just be patient. The News will be worth the short wait. I hope we will get the news the in the morning.
Why NAVB fall in the last few hours? Have you ever heard of those things called "Daytraders and shorts sellers". You know vicious little pint size furry creatures with very short pea size brains. The furry creatures is creepy crawling all over the stock price today. If you don't want the creepy crawlers in your stocks, just burn them out. They lite up like gasoline rain. lol.
Since Cardinal Health may not be buying out or merging with Navidea, imo, I would say very soon.
In my own opinion, I think CAH will come out better buying NAVB completely out... lock, stock, and barrel. The company will be more value to CAH, or any other company as a whole. Giving Navidea $310 million just for the sale of Lymphoseek in North America is just a drop in the bucket. The real money is in the ownership of the whole company and it collection of goodies.The Arthritis studies is going to turn out to be a bigger Gem than Lymphoseek for imaging. You know how many people out there is prone to Rheumatoid Arthritis. Having a drug or treatment that can diagnosis a patient for potential RA is money in the bank.
This one deal that NAVB is hoping that Cardinal Health will sign immediately. Navidea will be the big winner of this deal. Why you think they have not release the test result of the RA pre trial study of injecting lymphoseek in to patient with and without RA. When the deal is sign watch how quick NAVB positive test results start popping out into the markets. And not to mention the Cardiovascular disease studies at the medical college gearing up to start using lymphoseek in its cardiovascular disease trial studies.
I don't know about you guys, but I'am loading here with NAVB for the big payoff. Forget the nickle and dime profits. The big money is right around the corner. When we get comformation of the deal signed with Navidea and Cardinal Health. Next the pre trial study of the test result of RA patients. Then again Buyout potential is still lurking around.
Navidea is signing a sweet deal to sale Lymphoseek to cardinal Health North America division for $310 Million, and $80 million upfront in closing of the deal. Plus Navidea will be continuing its sales of Lymthoseek to other parts of the world. Best part of this deal for Navidea biopharamaceuticals there is no financing, and lots of cash flow to continue developing, marketing and sales of other products. Plus continue payments from Cardinal Health, and CAH licensing back of intellectual property to Navidea.
What a sweet deal, but I sense a complete buyout coming very soon.
Watch for a big move period. This company has stuck gold for the company and shareholders.
Digger keep in mind, Navidea will have all the funding it will need without any toxin financing, or financing period. I love it when a company can come out of debt without adding on more financing. The sale of Lymphoseek in North America for $310 million, and $80 million upfront in closing from Cardinal Health, is a very sweet deal. Plus Cardinal Health licensing back to Navidea a portion of the acquired intellectual property. Navidea can continue it's sales of Lymphoseek to other parts of the world.This help to put Navidea into a very powerful position in the rest of the world developing, manufacturing, marketing, and sales of Lymphoseek, with the large amount of capital on hand and continuing cash payments from CAH.
I smell a complete buyout of NAVB.
No. That is not it. Did you listen to the conference call yesterday. Navidea is going to received $80 million upfront from Cardinal Health inc. during closing of the deal to sale Lymphoseek in North America to Cardinal Health inc (CAH). Navidea will be paid $310 million from Cardinal Health inc to continue developing, manufacture, marketing, and sale of Lymphoseek.
Cardinal Health would license back to Navidea a portion of the acquire intellectual property. NVIDEA will be able to develop, manufacture, market, sell products that don't compete with current Lymphoseek in North America. Navidea will be able to continue to sell Lymphoseek out side of North America. Those revenue and profits made out side of North America will be Navidea profits and revenue. Plus Cardinal Health will continue to pay Navidea a total of $310 million for Lymphoseek.
Navidea will continue develop their other assets such as Rheumatoid Arthritis and Cardiovascular disease drugs.The CEO stated there will be no need to seek financing to continue its developing of other assets they're developing. Proceeds from the sale of Lymphoseek to CAH in North America will give Navidea the capital it need to pay debt and grow the company.
There is no need for the pps to fall down to the .20 or 50's. Navidea will have all the capital it will need to continue it's developing, manufacture, marketing, sales, and normal business activities.
Yes, I'am sure. Plus I'am doing lots of research on Navidea. I Notice on the company website news page, test results is due for Navidea study trial of Rheumatoid Arthritis employing IV-administration in the 2nd half of 2016 test results is due. Those test results could be release at any time. That might explain some of the inside buying going on. A positive test result and the go ahead from the FDA will give Navidea clearance to go to the next trial phase. In my research Navidea is working on several trial phases involving one of their main FDA approve drugs to treat other medical conditions such as Rheumatoid Arthritis. Lots of positive data.
navidea will received over 310 million dollars from CAH for the sale of one of its drugs for the North American region only. Plus CAH is leasing back to Navidea to continuing on marketing the drug in other countries and to manufacture it for CAH. Let me go back and look up the correct name of the drug and the correct name for CAH.
If anyone want to know where I found this information, it is on the company's website news.
Those was day-traders selling near the bell gearing up for tomorrow. I believe that NAVB is cleaning house and making room for a big buyout. This has buyout written all over it. The Signs are there.
This is going to be a beast when it re-visit the $1.10 again. The deal will get rib of debt and add a pile of cash flow. The company has three other major assets. We could soar up to $1.35 tomorrow.
If the company won't let you guys share value increase, than come over here to where we're. The company and mm let the pps run from 40 to over a $1. We received a pr yesterday now we are over $1.08 today. We're still over a dollar. IMNP won't let it shareholders value increase. They're all for themselves.
Thank you. Yes, this one is a gem.
I been here every since 53 yesterday. Almost double my investment. Congratulation to all here who held on.
It might just make a late afternoon move like *NAVB* did yesterday. It stay around .54 after it made a pull back and around 2:45 it made a very big move to .83 cent. I believe is going to do the same. It is holding up very well above .37 just need to break thru the .40 the next time it reach that magic number.
Good Luck everyone.
I'am waiting for that bit of positive news of a re-work contract deal with Foxcom., which will send XCOM soaring.
I'm looking for XCOM to go back to the 80's today. There is news on small caps popping up all over the place today. Waiting to see will XCOM do the same. We get news this is going to $1.50 very quickly.
I'm sorry expuman, my power went off we're experiencing hurricane weather here in Central Florida. I had to go over to the other side of the lake and bring my boat home and make it more secured. One thing about owning one of these big azz boats it is hard to secure it during a hurricane storm. My neighbors is beginning to piss me off, because my brother is using 2 semi trackers to secure it with by putting it between my boat ramp and deck house. I have been out here in this bad weather every since 3:30 to 9pm. Miss what happen with XCOM power has been continence going out. I see it is still in the eighties. Good, because I left an open order, taking the chance that XCOM might go even higher tomorrow.
I made a very nice profit, so I won't lose any capital if it should drop down to 70 or 65. I'am prepared to do what I have been doing since yesterday and today, and that is to knock the hell out of a fake "ask" again. The mm really tried to pull one over on us XCOM shareholders. But with team work we push the share price back up. I was hitting those low and mid fifties hard. It all paid off.
Okay, Expuman, my pullback is coming up. I'am looking to get in around .67 maybe even a little higher.
Correction: I should have gotten back in at 70, but it is too late. Guys please excuse my very bad grammar. I'am just so glad many shareholders whom held on made back their money today, or at less most of it.
I should have gotten back in at 70 but its to let.
Dame we made over a 30 cent run per share today. Without news from the oldies. Wish do believe we're going to get a nice pr. I'am put half of my profit back in at the end of the day.